Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Genset and Johnson & Johnson collaborate in the area of schizophrenia

Oct. 4, 1996

No Comments

New antipsychotic agents from Janssen

Oct. 4, 1996

No Comments

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

No Comments

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

No Comments

Merck & Co. reports 5-HT1Dalpha receptor agonists

Oct. 4, 1996

No Comments

Janssen describes vasoconstrictors for migraine Rx

Oct. 4, 1996

No Comments

Potential of cannabinoid derivative in pain and inflammation

Oct. 4, 1996

No Comments

Tachykinin antagonists disclosed by Sanofi

Oct. 4, 1996

No Comments

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Sep. 27, 1996

No Comments

Yamanouchi describes AMPA antagonists for stroke

Sep. 27, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Genset and Johnson & Johnson collaborate in the area of schizophrenia

New antipsychotic agents from Janssen

5-HT2B/2C antagonists disclosed by SKB

Novel benzodiazepine derivatives from Roche

Merck & Co. reports 5-HT1Dalpha receptor agonists

Janssen describes vasoconstrictors for migraine Rx

Potential of cannabinoid derivative in pain and inflammation

Tachykinin antagonists disclosed by Sanofi

Glaxo Wellcome prepares a novel class of glycine-site NMDA receptor antagonists

Yamanouchi describes AMPA antagonists for stroke

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Neurology/psychiatric RSS

Neurology/psychiatric
RSS